The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
Nitazenes can be up to 50 times stronger than fentanyl. They’re not yet common in Australia, so now’s the time to implement policies to reduce their harm and limit their uptake.
Researchers have completed Australia’s most detailed analysis of opioid tapering trajectories to date, with some findings that contradict current guidelines.
A new five-year study aims to build a broad picture of illicit drug use in regional Victoria, to better-understand the gaps in local health service planning.
While fentanyl is yet to markedly impact Australia, the North American opioid crisis shows us how bad it can get, and urgent action is needed now.
Changes to the Pharmaceutical Benefits Scheme have influenced the way doctors prescribe opioids, but is it for the better?
A new, long-acting formulation of the medication buprenorphine promises to improve the treatment of opioid dependence.
There's growing evidence that an escape from underlying physical or emotional pain is a common driver of many opioid overdoses.
New rules aim to curb opioid-related deaths in Australia. These changes are a step in the right direction, but we need to tread carefully to avoid unintended consequences.
Maintaining or expanding addiction services is vital if we’re to avert a syndemic of opioid overdoses and COVID-19.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioids are among the most powerful analgesics available to medicine, but they have huge capacity to cause harm. In trying to solve one problem, is a bigger one being created?
The drug epidemic that's claimed thousands of lives in the US is swiftly becoming a threat to the health of many Australians.
Dummy text
